RANDOMISED CONTROLLED TRIAL OF INTRAMUSCULAR PENTAZOCINE VERSUS INTRAMUSCULAR DICLOFENAC FOR PAIN RELIEF DURING MANUAL VACUUM ASPIRATION AT FEDERAL TEACHING HOSPITAL KATSINA.
Phase 1
- Conditions
- PAIN RELIEF DURING MANUAL VACUUM ASPIRATIONPAIN RELIEF DURING MANUAL VACUUM ASPIRATIO
- Registration Number
- PACTR202212482289582
- Lead Sponsor
- Dr Abe Abidemi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
ALL CONSENTING WOMEN WHO PRESENTED WITH A MISCARRIAGE OF LESS THAN 12 WEEKS FOR MANUAL VACUUM ASPIRATIO
Exclusion Criteria
MVA FOR ANY OTHER INDICATION APART FROM MISCARRIAGE.
OBESITY
WOMEN IN WHOM DICLOFENAC IS CONTRAINDICATED LIKE THOSE WITH PEPTIC ULCER DISEASE.
HISTORY OF HYPERSENSITIVITY TO PENTAZOCINE OR DICLOFENAC.
USE OF ANY KIND OF ANALGESIA WITHIN 12 HOURS.
UNCONSCIOUS PATIENTS.
PATIENTS IN SHOCK REQUIRING RESUSCITATION.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PAIN PERCEPTION USING VISUAL ANALOGUE SCORE
- Secondary Outcome Measures
Name Time Method PATIENT SATISFACTION USING LIKERT SCALE AND SIDE EFFECTS PROFILE